As of March 2026 CRISPR Therapeutics has a market cap of โน426.86 Billion. This makes CRISPR Therapeutics the world's 3183th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 18th, 2026 the market cap of CRISPR Therapeutics was reported to be: